DexCom (Ticker: DXCM) with Nick Sciple
Chit Chat Stocks
00:00
Is DEXCOM the Clear Choice on the Patient Side?
There are two risks. I think one is more obvious that investors are probably seeing if, you know, recently is the Apple leak about the glucose monitoring thing they're trying to do. Can you talk about how DEXCOM might have an advantage there and why this might not be as big of a deal of news? And then secondly, the new weight loss pills, maybe hit Apple and then the potential threat. Yeah. So assuming that you can get, get re-emperson for the insurance payer and, and all prices are aligned across the board, then, You know, DEXCOM is kind of the clear choice on the patient side.
Transcript
Play full episode
